Koehrer S - Search Results

1

Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivo.

Jaeger-Lansky A, Cejka D, Ying L, Preusser M, Hoeflmayer D, Fuereder T, Koehrer S, Wacheck V. Jaeger-Lansky A, et al. Among authors: koehrer s. Cancer Biol Ther. 2010 Jun 1;9(11):919-27. doi: 10.4161/cbt.9.11.11805. Epub 2010 Jun 18. Cancer Biol Ther. 2010. PMID: 20404549 Free article.

2

mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivo.

Fuereder T, Jaeger-Lansky A, Hoeflmayer D, Preusser M, Strommer S, Cejka D, Koehrer S, Crevenna R, Wacheck V. Fuereder T, et al. Among authors: koehrer s. Cancer Lett. 2010 Oct 28;296(2):249-56. doi: 10.1016/j.canlet.2010.04.015. Epub 2010 May 14. Cancer Lett. 2010. PMID: 20471160

3

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.

Werzowa J, Koehrer S, Strommer S, Cejka D, Fuereder T, Zebedin E, Wacheck V. Werzowa J, et al. Among authors: koehrer s. J Invest Dermatol. 2011 Feb;131(2):495-503. doi: 10.1038/jid.2010.327. Epub 2010 Nov 4. J Invest Dermatol. 2011. PMID: 21048785 Free article.

4

Ibrutinib inhibits pre-BCR⁺ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.

Kim E, Hurtz C, Koehrer S, Wang Z, Balasubramanian S, Chang BY, Müschen M, Davis RE, Burger JA. Kim E, et al. Among authors: koehrer s. Blood. 2017 Mar 2;129(9):1155-1165. doi: 10.1182/blood-2016-06-722900. Epub 2016 Dec 28. Blood. 2017. PMID: 28031181 Free PMC article.

5

B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies.

Koehrer S, Burger JA. Koehrer S, et al. Clin Adv Hematol Oncol. 2016 Jan;14(1):55-65. Clin Adv Hematol Oncol. 2016. PMID: 27057669 Review.

6

Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.

Randhawa S, Cho BS, Ghosh D, Sivina M, Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M, Burger JA. Randhawa S, et al. Among authors: koehrer s. Br J Haematol. 2016 Aug;174(3):425-36. doi: 10.1111/bjh.14075. Epub 2016 Apr 12. Br J Haematol. 2016. PMID: 27071778 Free PMC article.

7

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia.

Blunt MD, Koehrer S, Dobson RC, Larrayoz M, Wilmore S, Hayman A, Parnell J, Smith LD, Davies A, Johnson PWM, Conley PB, Pandey A, Strefford JC, Stevenson FK, Packham G, Forconi F, Coffey GP, Burger JA, Steele AJ. Blunt MD, et al. Among authors: koehrer s. Clin Cancer Res. 2017 May 1;23(9):2313-2324. doi: 10.1158/1078-0432.CCR-16-1662. Epub 2016 Oct 3. Clin Cancer Res. 2017. PMID: 27697994 Free PMC article.

8

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.

Koehrer S, Keating MJ, Wierda WG. Koehrer S, et al. Leukemia. 2010 May;24(5):1096-8. doi: 10.1038/leu.2010.45. Epub 2010 Mar 25. Leukemia. 2010. PMID: 20339441 No abstract available.

9

Chronic Lymphocytic Leukemia: Disease Biology.

Koehrer S, Burger JA. Koehrer S, et al. Acta Haematol. 2024;147(1):8-21. doi: 10.1159/000533610. Epub 2023 Sep 16. Acta Haematol. 2024. PMID: 37717577 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters